Stock SXTP 60 DEGREES PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart 60 Degrees Pharmaceuticals, Inc.

Equities

SXTP

US83006G1040

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-07-02 EDT 		5-day change 1st Jan Change
0.2401 USD -6.94% Intraday chart for 60 Degrees Pharmaceuticals, Inc. -14.34% -76.46%
06-27 60 Degrees Pharmaceuticals, Inc. Announces First Patient Enrolled in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis at Tufts Medical Center CI
05-30 60 Degrees Pharmaceuticals, Inc. Enters into an Agreement with Tufts Medical Center in Boston to Conduct the First Clinical Trial of Tafenoquine in Treating Human Babesiosis Patients CI
5ec2b0c7b39a38cdb9.Ucmh1gos3BFLz0m2y0JAmK_Xi8kKGZFxsck4oNYGdyo.PabDsGtzr34Zt3HfkwQo28Ces6doTdsZ-69u54doD3kwp_i1U0K7RRmqDA~540734c542cfb9e0cd9a5f26b7109465
  1. Stock Market
  2. Equities
  3. SXTP Stock
  4. Charts 60 Degrees Pharmaceuticals, Inc.
  5. News Chart